Tariq Naeem
May 07, 2024 | The Legal Intelligencer
Reform of Federal Marijuana Law and Potential Impacts on State Medical Marijuana ProgramsMomentum has been gathering behind efforts to reclassify marijuana under the Controlled Substances Act (CSA). Regardless of how marijuana is rescheduled under federal law, the Food and Drug Administration (FDA) could consider medical marijuana products to be unapproved "new drugs" subject to regulation under the Food, Drug, and Cosmetic Act (FDCA).
By Tariq Naeem
8 minute read
Trending Stories
- 1The Law Firm Disrupted: For Big Law Names, Shorter is Sweeter
- 2How I Made Office Managing Partner: 'If You Are Aware of Areas for Improvement and You Can Play a Role in That, Speak Up,' Says Jennifer Mellott of Freshfields
- 3'I'm Staying Everything': Texas Bankruptcy Judge Halts Talc Trials Against J&J
- 4What We Know About the Kentucky Judge Killed in His Chambers
- 5Burns & Levinson to Wind Down After 64 Years in Boston
More from ALM
- Morgan & Morgan Class Action Attorneys Detail Pathway to Success Within Cybersecurity and Data Privacy Practice 1 minute read
- Holwell Shuster & Goldberg Partners Leverage 'Hostile' Witnesses to Secure $101 Million Verdict Against Walmart 1 minute read
- Legal Speak at General Counsel Conference Midwest 2024: Mike Andolina, Partner, White & Case 1 minute read